Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design…
karnottMay 27, 2024
adMare BioInnovations (adMare) is pleased to announce the acceptance of five therapeutics start-ups from across…
karnottMay 24, 2024
Dr. Sally Otto—a theoretical biologist focused on fundamental questions of population genetics and evolution—has been…
karnottMay 24, 2024
High-grade serous ovarian cancer (HGSC) is a challenging disease, especially for patients with immunologically “cold”…
karnottMay 23, 2024
New evidence underscores the importance of conducting follow-up biopsies in children after treatment for rejection…
karnottMay 23, 2024
The effectiveness of radiotherapy depends on the sensitivities of ‘normal’ and cancer cells to the…
karnottMay 22, 2024
An interdisciplinary UBC team led by Dr. Peter Zandstra has received $1.65 million in federal…
karnottMay 22, 2024
Congratulations to Emily Yeh (Terry Fox Laboratory), for receiving a Canada Graduate Scholarships - Master's…
karnottMay 21, 2024
A growing body of evidence shows that the granzyme family of enzymes offer new pathways…
karnottMay 21, 2024
